Product Program year 2025 Source: CMS Open Payments

Fracture and Correction Colag 2

Device In2bones

PDI 00817906025569

Open in the dashboard

General payments

$487,129

295 payments

Research payments

$0

0 payments

Through program year 2025, $487,129 in general payments and $0 in research payments were reported against Fracture and Correction Colag 2 (In2bones).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $153,844 110
2024 General $21,717 48
2023 General $311,568 137

Breakdown

Who paid General payments · program years 2023–2025
  1. Linvatec Corporation $487,129 295 payments
Top recipients General payments · program year 2025
  1. Travis Hanson Orthopaedic Surgery · Houston, TX $80,204 52% · 10 payments
  2. Kevin Varner Foot and Ankle Surgery · Houston, TX $56,923 37% · 5 payments
  3. Gary Stewart Orthopaedic Surgery · McDonough, GA $5,400 4% · 6 payments
  4. Jason Snyder Podiatrist, Foot & Ankle Surgery · New York, NY $2,095 1% · 3 payments
  5. Waldemar Majdanski Podiatrist · Astoria, NY $1,295 <1% · 3 payments

The top 5 of 78 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Orthopaedic Surgery $86,523 56% · 10 practitioners
  2. Foot and Ankle Surgery Orthopaedic Surgery $57,873 38% · 8 practitioners
  3. Podiatrist, Foot & Ankle Surgery Podiatrist $5,104 3% · 38 practitioners
  4. Podiatrist $3,416 2% · 14 practitioners
  5. Podiatrist, Foot Surgery Podiatrist $667 <1% · 5 practitioners

The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $137,595 89% · 4 recipients
  2. Georgia $5,400 4% · 1 recipient
  3. New York $5,043 3% · 21 recipients
  4. Florida $1,890 1% · 25 recipients
  5. Virginia $1,118 <1% · 8 recipients

The top 5 of 16 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

295 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record